Head-to-head · Value Score
CoreAge Rx vs DrMedHealth
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, DrMedHealth a 68. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameDrMedHealth
#268 · Grade C · Watch List
Est. first month
From $199/mo (starting dose, compounded)
Save ~85% vs brand-nameFDA warning letter. The FDA issued Public Health Solution LLC dba DrMedHealth a warning letter in June 2026. Check it on the FDA database.
Get this deal Full DrMedHealth review →The verdict
CoreAge Rx takes it on Value Score, 93 to 68 — an est. $99/mo first month, with no teaser step-up baked in. DrMedHealth isn't out of it: Someone who wants an oral option without paying a premium for it, and wants approval fast.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | DrMedHealth |
|---|---|---|
| Value Score | 93 (A+) | 68 (C) |
| Est. first month | $99/mo | From $199/mo (starting dose, compounded) |
| Save vs brand-name | ~89% | ~85% |
| Semaglutide | $99/mo | From $199/mo (starting dose, compounded) |
| Tirzepatide | $149/mo | From $299/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
DrMedHealth
DrMedHealth is a LegitScript-certified telehealth service selling compounded semaglutide from $199 a month as either an injection or an oral tablet, and tirzepatide from $299, with approval quoted in 2 to 24 hours.
Why it's a deal
- LegitScript certified, stated on its own site rather than implied
- Semaglutide is offered as an oral tablet as well as an injection, and the advertised entry price is the same for both
- Approval quoted at 2 to 24 hours, with free shipping from a licensed US pharmacy inside 1 to 2 business days
- The price is described as all-inclusive, covering 24/7 medical support, dosage adjustments and ongoing monitoring
The fine print
- The advertised figures are entry rates and the site does not publish what higher doses cost
- Cash-pay — insurance is generally not accepted for the medication
- The full list of states served is not consolidated anywhere on the site
- Compounded GLP-1s are not FDA-approved for safety, efficacy or quality
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to DrMedHealth.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.